Akèy › Maladi Parkinson › New York
Etid klinik pou Maladi Parkinson nan New York
31 etid pou Maladi Parkinson ap chèche patisipan nan sit nan New York.
Vil nan New York
Tèks ofisyèl etid la (Anglè)
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
- Northwell Health, Manhasset
- Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
- Columbia University, New York
- ak 1 plis
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Oct 2, 2026 · NCT06680830Visual Hallucinations in Lewy Body Diseases
- NYU Langone Health, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 90 · Tout sèks · Mizajou Sep 30, 2026 · NCT07849413A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Site-006, Albany
- Site-005, New York
Ap rekriteFaz 2/3
Laj 40 a 80 · Tout sèks · Mizajou Sep 28, 2026 · NCT06976268GBPDC: Gut-Brain in PD Consortium Master Protocol
- Columbia University, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 21 a 80 · Tout sèks · Mizajou Sep 25, 2026 · NCT07567794Speech Learning and Speech Production in Parkinson's Disease
- State University of New York at Buffalo, Buffalo
Ap rekrite
Laj 45 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07403539A Study of Buntanetap in Participants With PD
- Mount Sinai Hospital, New York
Ap rekriteFaz 2/3
Laj 40 a 85 · Tout sèks · Mizajou Sep 21, 2026 · NCT07284784Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
- Weill Cornell Medical College, New York
Ap rekriteFaz 2
Laj 40 a 80 · Tout sèks · Mizajou Sep 21, 2026 · NCT07005180Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Northwell Health Neuroscience Institute, Great Neck
- University at Buffalo, Williamsville
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT02071134A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
- Vima Site #055, Amherst
- Vima Site #024, New York
- Vima Site #052, Patchogue
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Sep 11, 2026 · NCT07804615A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
- Joan and Sanford I. Weill Department of Medicine (Site #224), New York
- Mount Sinai School of Medicine (Site #209), New York
Ap rekriteFaz 2
Laj 30 a 80 · Tout sèks · Mizajou Sep 10, 2026 · NCT07432958Parkinson's Foundation PD GENEration Genetic Registry
- Mount Sinai, New York
- Columbia University, New York
- University of Rochester Medical Center, Rochester
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT04994015A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
- Northwell Health, New York
- Stony Brook University, Stony Brook
- University of Buffalo Jacobs School of Medicine, Williamsville
Ap rekriteEtid obsèvasyon
Laj 45 a 75 · Tout sèks · Mizajou Sep 4, 2026 · NCT07330258Deep Brain Stimulation (DBS) Retrospective Outcomes Study
- Albany Medical Center, Albany
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 3, 2026 · NCT03664609A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Dent Neurological Institute, Amherst
- Parkinson's Research Centers of America - Long Island, Commack
- Weill Cornell Medical College, New York
- ak 1 plis
Ap rekriteFaz 3
Laj 50 a 85 · Tout sèks · Mizajou Sep 3, 2026 · NCT07174310Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
- University of Rochester Center for Health and Technology (CHeT), Rochester
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06993142Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
- NYU Langone Health, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT07752355A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
- UBMD Neurology, Buffalo
- Mount Sinai West - Neurology, New York
- New York Presbyterian/Weill Cornell Medical Center, New York
Ap rekriteFaz 3
Laj 45 a 75 · Tout sèks · Mizajou Aug 4, 2026 · NCT06944522Autoimmune Features of Neurodegenerative Disorders
- Columbia University Medical Center, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 55 a 90 · Tout sèks · Mizajou Aug 4, 2026 · NCT04239079Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
- Radial Midtown Manhattan, New York
Ap rekrite
Laj 22 a 80 · Tout sèks · Mizajou Jul 31, 2026 · NCT07207122PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
- University of Rochester, Rochester
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 30 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT04477785Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease Subjects
- New York Institute of Technology - College of Ostopathic Medicine - Academic Health Care Center - Osteopathic Medicine Center, Old Westbury
Ap rekrite
Tout laj · Tout sèks · Mizajou Jun 29, 2026 · NCT06671600Natural History Study of Synucleinopathies
- NYU Medical Center, New York
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT01799915Parkinson's Disease Biomarkers in Nerve Cells in the Gut
- Weill Cornell Medicine, New York
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou May 22, 2026 · NCT05347407This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
- Cornell University Weill Medical College, New York
Ap rekriteFaz 1/2
Laj 30 a 75 · Tout sèks · Mizajou May 11, 2026 · NCT07102342A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
- Weill Cornell Medicine, New York
Ap rekriteEtid obsèvasyon
Laj 30 a 99 · Tout sèks · Mizajou Mar 20, 2026 · NCT05539196A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
- New York Presbyterian Hospital-Columbia University Medical Center, New York
Ap rekriteFaz 1/2
Laj 40 a 72 · Tout sèks · Mizajou Mar 2, 2026 · NCT06753331Abbott DBS Post-Market Study of Outcomes for Indications Over Time
- Albany Medical Center, Albany
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jan 8, 2026 · NCT04071847Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
- Parkinson's Disease and Movement Disorders Center - Long Island, Commack
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Oct 22, 2025 · NCT07219927A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
- Parkinson's Research Centers of America - Long Island, Commack
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2025 · NCT06765668NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
Ap rekriteEtid obsèvasyon
30 Days · Tout sèks · Mizajou Mar 3, 2025 · NCT06203106Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
- Teachers College, Columbia University, New York
Ap rekriteFaz 1 bonè
Laj 50 a 80 · Tout sèks · Mizajou Aug 15, 2024 · NCT06540989Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.